Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: Implications in drug solubilization and delivery

Jeong, 2002, Thermosensitive sol–gel reversible hydrogels, Adv. Drug Deliv. Rev., 54, 37, 10.1016/S0169-409X(01)00242-3 Klouda, 2008, Thermoresponsive hydrogels in biomedical applications, Eur. J. Pharm. Biopharm., 68, 34, 10.1016/j.ejpb.2007.02.025 Rangel-Yagui, 2005, Micellar solubilization of drugs, J. Pharm. Pharm. Sci., 8, 16 Dumortier, 2006, A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm. Res. Dord., 23, 2709, 10.1007/s11095-006-9104-4 Alexandridis, 1994, Micellization of poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association, Macromolecules, 27, 2414, 10.1021/ma00087a009 Liu, 2000, Amphiphilic polyoxyalkylene triblock copolymers: self-assembly, phase behaviors, and new applications, 2 Desai, 2001, Effect of additives on the micellization of PEO/PPO/PEO block copolymer F127 in aqueous solution, Colloids Surf. A: Physicochem. Eng. Asp., 178, 57, 10.1016/S0927-7757(00)00493-3 Pandit, 1996, Loss of gelation ability of Pluronic® F127 in the presence of some salts, Int. J. Pharm., 145, 129, 10.1016/S0378-5173(96)04748-5 Pandit, 2000, Effect of salts on the micellization, clouding, and solubilization behavior of Pluronic F127 solutions, J. Colloid Interf. Sci., 222, 213, 10.1006/jcis.1999.6628 Bohorquez, 1999, A study of the temperature-dependent micellization of Pluronic F127, J. Colloid Interf. Sci., 216, 34, 10.1006/jcis.1999.6273 Wu, 2005, Effect of EO and PO positions in nonionic surfactants on surfactant properties and demulsification performance, Colloids Surf. A: Physicochem. Eng. Asp., 252, 79, 10.1016/j.colsurfa.2004.09.034 Cafaggi, 2008, Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation, Eur. J. Pharm. Sci., 35, 19, 10.1016/j.ejps.2008.05.010 Ricci, 2005, Sustained release of lidocaine from poloxamer 407 gels, Int. J. Pharm., 288, 235, 10.1016/j.ijpharm.2004.09.028 Veyries, 1999, Controlled release of vancomycin from poloxamer 407 gels, Int. J. Pharm., 192, 183, 10.1016/S0378-5173(99)00307-5 Rodriguez-Perez, 2006, Solubilization and delivery from cyclodextrin-pluronic aggregates, J. Nanosci. Nanotechnol., 6, 3179, 10.1166/jnn.2006.472 Bilensoy, 2007, Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer, J. Incl. Phenom. Macro., 57, 363, 10.1007/s10847-006-9259-y Mahajan, 2011, Nasal in situ gel containing hydroxy propyl β-cyclodextrin inclusion complex of artemether: development and in vitro evaluation, J. Incl. Phenom. Macro., 70, 49, 10.1007/s10847-010-9861-x Cho, 2011, Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride, J. Pharm. Sci., 100, 681, 10.1002/jps.22314 Jansook, 2010, Gamma CD/HP gamma CD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension, J. Pharm. Pharm. Sci., 13, 336, 10.18433/J3M88B Kim, 2009, Thermo-reversible flurbiprofen liquid suppository with HP-beta-CD as a solubility enhancer: improvement of rectal bioavailability, J. Incl. Phenom. Macro., 64, 265, 10.1007/s10847-009-9560-7 Jansook, 2009, CDs as solubilizers: effects of excipients and competing drugs, Int. J. Pharm., 379, 32, 10.1016/j.ijpharm.2009.06.005 Nogueiras-Nieto, 2009, Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state, J. Phys. Chem. B, 113, 2773, 10.1021/jp809806w Huang, 2005, Polypseudorotaxanes and polyrotaxanes, Prog. Polym. Sci., 30, 982, 10.1016/j.progpolymsci.2005.07.003 Wenz, 2006, Cyclodextrin rotaxanes and polyrotaxanes, Chem. Rev., 106, 782, 10.1021/cr970027+ Otero-Espinar, 2010, Cyclodextrins in drug delivery systems, J. Drug Deliv. Sci. Technol., 20, 289, 10.1016/S1773-2247(10)50046-7 Loethen, 2007, Biomedical applications of cyclodextrin based polyrotaxanes, Polym. Rev., 47, 383, 10.1080/15583720701455145 Yamashita, 2008, Supramolecular control of polyplex dissociation and cell transfection: efficacy of amino groups and threading cyclodextrins in biocleavable polyrotaxanes, J. Control. Release, 131, 137, 10.1016/j.jconrel.2008.07.011 L. Nogueiras-Nieto, F.J. Otero-Espinar, Promotion of triamcinolone acetonide permeation through calf hooves from thermosensitive hydrogels containing Pluronic F127 and cyclodextrins, in: 15th International Cyclodextrin Symposium, Viena, 2010, p. 028. Villar-Lopez, 1999, Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting, Int. J. Pharm., 179, 229, 10.1016/S0378-5173(98)00369-X Loftsson, 2005, Evaluation of cyclodextrin solubilization of drugs, Int. J. Pharm., 302, 18, 10.1016/j.ijpharm.2005.05.042 Siemoneit, 2006, Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability, Int. J. Pharm., 312, 66, 10.1016/j.ijpharm.2005.12.046 Uekama, 1987, Cyclodextrins in drug carrier systems, CRC Crit. Rev. Ther. Drug Carrier Syst., 3, 1 Higuchi, 1965, Phase-solubility techniques, Adv. Anal. Chem. Instrum., 4, 117 Loftsson, 2005, Evaluation of cyclodextrin solubilization of drugs, Int. J. Pharm., 302, 18, 10.1016/j.ijpharm.2005.05.042 Loftsson, 2007, The complexation efficiency, J. Incl. Phenom. Macro., 57, 545, 10.1007/s10847-006-9247-2 Masson, 1999, Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing, J. Control. Release, 59, 107, 10.1016/S0168-3659(98)00182-5 Landy, 2007, Development of a competitive continuous variation plot for the determination of inclusion compounds stoichiometry, J. Incl. Phenom. Macro., 57, 409, 10.1007/s10847-006-9226-7 Loftsson, 2002, Cyclodextrins and drug permeability through semi-permeable cellophane membranes, Int. J. Pharm., 232, 35, 10.1016/S0378-5173(01)00895-X Loftsson, 2004, Self-association of cyclodextrins and cyclodextrin complexes, J. Pharm. Sci., 93, 1091, 10.1002/jps.20047 Loftsson, 2007, Effects of cyclodextrins on drug delivery through biological membranes, J. Pharm. Sci., 96, 2532, 10.1002/jps.20992